Drug intelligence / Profile preview

dexamethasone sodium phosphate

Development stage
Approved
Lead developer
Merck
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Intravenous, Intramuscular, Ophthalmic, Intraarticular, Intralesional, Soft Tissue Injection, Oral, Topical, Otic, Intravitreal
01

Overview

Dexamethasone sodium phosphate is a synthetic adrenocortical steroid and a water-soluble inorganic ester of dexamethasone, classified as a glucocorticoid. It is used primarily for its potent anti-inflammatory and immunosuppressive effects across multiple organ systems. The drug acts by binding to the glucocorticoid receptor, modulating gene expression to suppress inflammatory responses and immune activity. Dexamethasone sodium phosphate has rapid onset but short duration of action compared to less soluble corticosteroid preparations, making it suitable for acute conditions responsive to steroid therapy. Indications include endocrine disorders (such as adrenal insufficiency), rheumatic disorders (like rheumatoid arthritis), severe allergic reactions, certain skin diseases, eye inflammation, gastrointestinal diseases (e.g., ulcerative colitis), blood disorders, respiratory conditions (e.g., asthma), cerebral edema, neoplastic diseases (such as leukemia or lymphoma symptom relief), shock unresponsive to conventional therapy if adrenal insufficiency exists or is suspected, and other inflammatory or autoimmune conditions[1][4][5][6].

Brand names
DecadronMaxidexOzurdexDexPakDBL Dexamethasone Sodium Phosphate
Other names
dexamethasone phosphatedexamethasone disodium phosphate
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on dexamethasone sodium phosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexamethasone sodium phosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call